NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
Dialysis Technology Innovations: Revolutionizing Patient Care with Portable S...
Rising Chronic Kidney Disease Burden: A Global Health Challenge from 1990 to ...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
Fabhalta C3 glomerulopathy treatment Gains EMA Endorsement as First Targeted ...
Zircaix: A Potential Breakthrough in Kidney Cancer Diagnosis
Personalized Cancer Vaccine in High-Risk Kidney Cancer Patients
Advancing Cancer Treatment: Ivonescimab’s Potential and Strategic Collaborati...
ACS Management Innovations: Transforming Patient Outcomes in Acute Coronary S...
Global Childhood Cancer Access
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
Hypertension Detection: HTN-AI Model for Cardiovascular Risk Stratification
Lenacapavir HIV Prevention: Approval and Access Strategy Updates